Modulating the profit motive to meet needs of the less-developed world

Research output: Contribution to journalArticle

Abstract

The success, despite the problems, of academic/industrial collaborations over the past decade owes much to the profit motive. However, market-driven research and development has little to offer patients in the less-developed world. Some flexibility has already been demonstrated on drugs for orphan (rare or under-researched) diseases. Many diseases in less-developed countries are not rare. Academic researchers should be encouraging the establishment of funding for basic and clinical research that is directed at patients' needs in the less-developed world and that is independent of a commercial ethos.

Original languageEnglish
Pages (from-to)1638-1641
Number of pages4
JournalLancet
Volume358
Issue number9293
DOIs
Publication statusPublished - Nov 10 2001

Fingerprint

Orphan Drug Production
Marketing
Research
Developing Countries
Research Personnel

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Modulating the profit motive to meet needs of the less-developed world. / Schieppati, Arrigo; Remuzzi, Giuseppe; Garattini, Silvio.

In: Lancet, Vol. 358, No. 9293, 10.11.2001, p. 1638-1641.

Research output: Contribution to journalArticle

@article{52e34719b6a34e87a227ab97f188ae98,
title = "Modulating the profit motive to meet needs of the less-developed world",
abstract = "The success, despite the problems, of academic/industrial collaborations over the past decade owes much to the profit motive. However, market-driven research and development has little to offer patients in the less-developed world. Some flexibility has already been demonstrated on drugs for orphan (rare or under-researched) diseases. Many diseases in less-developed countries are not rare. Academic researchers should be encouraging the establishment of funding for basic and clinical research that is directed at patients' needs in the less-developed world and that is independent of a commercial ethos.",
author = "Arrigo Schieppati and Giuseppe Remuzzi and Silvio Garattini",
year = "2001",
month = "11",
day = "10",
doi = "10.1016/S0140-6736(01)06658-2",
language = "English",
volume = "358",
pages = "1638--1641",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Lancet Publishing Group",
number = "9293",

}

TY - JOUR

T1 - Modulating the profit motive to meet needs of the less-developed world

AU - Schieppati, Arrigo

AU - Remuzzi, Giuseppe

AU - Garattini, Silvio

PY - 2001/11/10

Y1 - 2001/11/10

N2 - The success, despite the problems, of academic/industrial collaborations over the past decade owes much to the profit motive. However, market-driven research and development has little to offer patients in the less-developed world. Some flexibility has already been demonstrated on drugs for orphan (rare or under-researched) diseases. Many diseases in less-developed countries are not rare. Academic researchers should be encouraging the establishment of funding for basic and clinical research that is directed at patients' needs in the less-developed world and that is independent of a commercial ethos.

AB - The success, despite the problems, of academic/industrial collaborations over the past decade owes much to the profit motive. However, market-driven research and development has little to offer patients in the less-developed world. Some flexibility has already been demonstrated on drugs for orphan (rare or under-researched) diseases. Many diseases in less-developed countries are not rare. Academic researchers should be encouraging the establishment of funding for basic and clinical research that is directed at patients' needs in the less-developed world and that is independent of a commercial ethos.

UR - http://www.scopus.com/inward/record.url?scp=0035841614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035841614&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(01)06658-2

DO - 10.1016/S0140-6736(01)06658-2

M3 - Article

C2 - 11716910

AN - SCOPUS:0035841614

VL - 358

SP - 1638

EP - 1641

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9293

ER -